Systemic immune‐inflammation index as a prognostic marker for advanced chronic heart failure with renal dysfunction

We aim to investigate the correlation between high levels of the systemic immune‐inflammation index (SII) and long‐term mortality and major cardiovascular adverse events in advanced chronic heart failure patients with renal dysfunction.

[1]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[2]  S. Ling,et al.  NETosis as a Pathogenic Factor for Heart Failure , 2021, Oxidative medicine and cellular longevity.

[3]  N. Frangogiannis,et al.  Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure , 2020, Cardiovascular Drugs and Therapy.

[4]  C. Tschöpe,et al.  Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis , 2020, ESC heart failure.

[5]  Xue Yan,et al.  Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer , 2020, Bioscience reports.

[6]  Jiong Lu,et al.  Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma , 2020, Medicine.

[7]  Sanjiv J. Shah,et al.  Renal Dysfunction in Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial. , 2020, Journal of cardiac failure.

[8]  G. Filippatos,et al.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2020, European heart journal.

[9]  F. Cosentino,et al.  The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.

[10]  Z. Shao,et al.  Prognostic value of prognostic nutritional index and systemic immune‐inflammation index in patients with osteosarcoma , 2019, Journal of cellular physiology.

[11]  K. Walsh,et al.  Wnt5a-Mediated Neutrophil Recruitment Has an Obligatory Role in Pressure Overload-Induced Cardiac Dysfunction. , 2019, Circulation.

[12]  Zhentao Yu,et al.  The predictive value of a preoperative systemic immune‐inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma , 2018, Journal of cellular physiology.

[13]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[14]  Ying-xin Zhao,et al.  Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention , 2018, Chinese medical journal.

[15]  H. Daida,et al.  Relationship between blood urea nitrogen-to-creatinine ratio at hospital admission and long-term mortality in patients with acute decompensated heart failure , 2018, Heart and Vessels.

[16]  Dana Stoian,et al.  Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases , 2017, Front. Immunol..

[17]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[18]  P. Kalra,et al.  Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease , 2017, Scientific Reports.

[19]  M. Borggrefe,et al.  Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients , 2017, Mediators of inflammation.

[20]  H. Anders,et al.  Histones and Neutrophil Extracellular Traps Enhance Tubular Necrosis and Remote Organ Injury in Ischemic AKI. , 2017, Journal of the American Society of Nephrology : JASN.

[21]  W. Guo,et al.  Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection , 2016, Clinical chemistry and laboratory medicine.

[22]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[23]  L. Tavazzi,et al.  Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry. , 2016, International journal of cardiology.

[24]  J. Carrero,et al.  Therapeutics targeting persistent inflammation in chronic kidney disease. , 2016, Translational research : the journal of laboratory and clinical medicine.

[25]  J. Keaney,et al.  Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications. , 2015, European heart journal.

[26]  S. Nourshargh,et al.  Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo , 2015, Immunity.

[27]  M. Rajappa,et al.  Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis? , 2015, Clinica chimica acta; international journal of clinical chemistry.

[28]  H. Pircher,et al.  Myocardial Ischemia and Reperfusion Leads to Transient CD8 Immune Deficiency and Accelerated Immunosenescence in CMV-Seropositive Patients , 2014, Circulation research.

[29]  A. Folsom,et al.  Obesity, subclinical myocardial injury, and incident heart failure. , 2014, JACC. Heart failure.

[30]  V. Kadirkamanathan,et al.  A Zebrafish Compound Screen Reveals Modulation of Neutrophil Reverse Migration as an Anti-Inflammatory Mechanism , 2014, Science Translational Medicine.

[31]  C. O'connor,et al.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. , 2014, European heart journal.

[32]  E. Grove,et al.  Platelet Turnover in Stable Coronary Artery Disease – Influence of Thrombopoietin and Low-Grade Inflammation , 2014, PloS one.

[33]  S. Prabhu,et al.  Integrative Physiology Methods and Results: We Evaluated C57bl/6 Mice with Chronic Hf 8 Weeks after Coronary Ligation. as Compared with Sham-operated Controls, Hf Mice Exhibited: (1) Increased Proinflammatory Cd11b , 2022 .

[34]  Luigi Tavazzi,et al.  Co‐morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey , 2014, European journal of heart failure.

[35]  P. Ponikowski,et al.  Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure , 2014, Circulation. Heart failure.

[36]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[37]  B. Kısacık,et al.  Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis , 2014, Inflammation.

[38]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[39]  J. Kasprzak,et al.  Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention. , 2013, Cardiology journal.

[40]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[41]  H. Feldman,et al.  CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. , 2012, Journal of the American Society of Nephrology : JASN.

[42]  M. Bjerre,et al.  Plasma calprotectin levels reflect disease severity in patients with chronic heart failure , 2012, European journal of preventive cardiology.

[43]  N. Uriel,et al.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome , 2012, Heart Failure Reviews.

[44]  P. Meda,et al.  Junctional adhesion molecule-C (JAM-C) regulates polarized neutrophil transendothelial cell migration in vivo , 2011, Nature Immunology.

[45]  E. Núñez,et al.  Effectiveness of the relative lymphocyte count to predict one-year mortality in patients with acute heart failure. , 2011, The American journal of cardiology.

[46]  Grace Y Chen,et al.  Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.

[47]  A. Buser,et al.  Use of myeloperoxidase for risk stratification in acute heart failure. , 2010, Clinical chemistry.

[48]  P. Ponikowski,et al.  Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  P. Ponikowski,et al.  Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[50]  S. Anker,et al.  Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. , 2009, Heart failure clinics.

[51]  H. Volk,et al.  Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  G. Navis,et al.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[53]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[54]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[55]  J. Schnermann,et al.  Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. , 2007, American journal of physiology. Renal physiology.

[56]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[57]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[58]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[59]  J. Mehta,et al.  Platelet Function Studies in Heart Disease: VI. Enhanced Platelet Aggregate Formation Activity in Congestive Heart Failure Inhibition by Sodium Nitroprusside , 1979, Circulation.